Biotechnology · Healthcare
Joanne Quan
Equibles does not estimate personal net worth.
Get an email with a short summary when Mirum Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get MIRM alertsAbout Joanne Quan
The proxy statement of Mirum Pharmaceuticals, Inc. reports total compensation of $3,246,216 for Joanne Quan in fiscal 2025, including a base salary of $520,000. Disclosed compensation is on record for 4 fiscal years. Joanne Quan has spoken on 4 earnings calls across 1 company, most recently for Mirum Pharmaceuticals, Inc. on May 6, 2026. Mirum Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Mirum Pharmaceuticals, Inc. includes Christopher Peetz (CEO), Michael Grey (CEO), Eric Bjerkholt (CFO) and 6 others.
Joanne Quan on recent calls
“When we look at the, you know, curves in terms of the virological response, we do see declines in everyone. So, you know, when you structure the endpoint, if you don't meet a certain point by week 24, then you're either on one side of line or the other.”
“2025 was an important year for our pipeline, and 2026 will be even more significant as multiple programs approach potentially registrational readouts. As Chris mentioned, enrollment across all our clinical studies is on track or ahead of previously communicated timelines.”
“With regards to your questions about VISTAs, you know, we're feeling pretty confident.”
“2024 was a highly productive year for our clinical programs, and I'm excited to continue this momentum into 2025.”
Affiliation history
-
Mirum Pharmaceuticals, Inc. (MIRM)
Proxy statement
CurrentStart not stated–present
Last confirmed April 23, 2024
Company network
Leadership on record at Mirum Pharmaceuticals, Inc.
- Christopher Peetz CEO
- Michael Grey CEO
- Eric Bjerkholt CFO
- Peter Radovich COO
- Lon Cardon, Ph.D., FMedSci Board Member
- Saira Ramasastry Board Member
- Timothy Walbert Board Member
- To approve Board Member
- William Fairey Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Medical Officer | $520,000 | $3,246,216 |
| 2024 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Medical Officer | $479,167 | $3,589,334 |
| 2023 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Medical Officer | — | — |
| 2022 | Mirum Pharmaceuticals, Inc. (MIRM) | Chief Medical Officer | — | — |